Quality Culture as enabler of high quality performance and subsequently as source of competitive advantage is increasingly discussed among OPEX and quality executives. Research studies indicate an impact of quality culture on performance, especially on the success of quality improvement programs such as Total Quality Management initiatives. A continual challenge in quality culture research however remains the lack of practical and accepted metrics to assess culture. In 2014 the Parental Drug Association (PDA) conducted a quality culture survey within the pharmaceutical industry. The results indicate a positive and significant correlation between Quality (Culture) Behavior of a production sites' employees and Quality (System) Maturity, which is representing the maturity of the quality system in place. As the maturity of the quality system is easier to assess by objective criteria, the positive correlation between Quality (Culture) Behavior and Quality (System) Maturity may be exploited by using the latter as indicator for quality culture. This paper confirms this positive relationship by exploring the comprehensive St.Gallen OPEX database for pharmaceutical production plants. Furthermore, data analysis shows that high performing production sites, in terms of timely provision of high quality drugs, reveal a higher level of both, Quality (System) Maturity and Quality (Culture) Behavior compared to low performing sites.
Language
English
HSG Classification
contribution to scientific community
Refereed
Yes
Publisher
PDA Journal of Pharmaceutical Science and Technology